Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-4-10
pubmed:abstractText
This study was undertaken to analyze genetic alterations in 108 sporadic serous ovarian neoplasms to elucidate ovarian serous carcinogenesis. Our results demonstrate that K-ras mutations occur in approximately 50% of serous borderline tumors (SBTs), non-invasive micropapillary serous carcinomas (MPSCs), and invasive micropapillary serous carcinomas, which represent a morphological continuum of tumor progression. Moreover, progressive increase in the degree of allelic imbalance of chromosomes 1p, 5q, 8p, 18q, 22q, and Xp was observed comparing serous borderline tumors to noninvasive and invasive micropapillary serous carcinomas. In contrast, high-grade (conventional serous carcinoma) tumors contained wild-type K-ras in all 23 cases studied and a high frequency of allelic imbalance even in small (early) primary tumors similar to that found in advanced stage tumors. Based on these findings, we propose a dualistic model for ovarian serous carcinogenesis. One pathway involves a stepwise progression from SBT to noninvasive and then invasive MPSC. The other pathway is characterized by rapid progression from the ovarian surface epithelium or inclusion cysts to a conventional (high-grade) serous carcinoma.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-10078924, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-10430926, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-10446448, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-10580104, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-11135558, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-11221861, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-11226292, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-11474297, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-7896180, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-8137211, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-8384077, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-8402612, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-8485726, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-8521410, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-8898836, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-8898837, http://linkedlifedata.com/resource/pubmed/commentcorrection/11943707-9633841
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0002-9440
pubmed:author
pubmed:issnType
Print
pubmed:volume
160
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1223-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Diverse tumorigenic pathways in ovarian serous carcinoma.
pubmed:affiliation
Department of Pathology, The Johns HopkinsUniversity School of Medicine, Baltimore, Maryland, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't